PHAXIAM Therapeutics S.A. Euronext Paris
Equities
PHXM
FR0011471135
Biotechnology & Medical Research
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
2.97 EUR | +0.68% | +1.71% | -35.43% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.01% | 108B | |
+11.17% | 104B | |
+1.43% | 22.33B | |
-12.04% | 22.19B | |
-7.05% | 18.69B | |
-38.36% | 17.74B | |
-10.36% | 17.64B | |
+5.84% | 14.05B | |
+34.91% | 12.51B |
- Stock Market
- Equities
- PHXM Stock
- PHXM Stock
- News PHAXIAM Therapeutics S.A.
- Erytech Pharma Gets FDA Fast Track Designation for Leukemia Treatment: Shares Jump